# Developmental origins and early detection of ADHD and dysregulatory psychopathology

> **NIH NIH R01** · OREGON HEALTH & SCIENCE UNIVERSITY · 2022 · $59,533

## Abstract

Project Summary (No change from Parent Award)
The goal of this proposal is to identify early life predictors of symptoms of ADHD and associated behavioral and
emotional problems. To do so children are followed from before birth to 4.5 years of age—on the cusp of school
entry and well into the preschool period. ADHD and related problems with behavioral and emotional
dysregulation are often not clinically identified until school age. By that point they are difficult to reverse. This
proposal answers calls in the literature for earlier identification of risk and for discovery of early life mechanisms
that can be targets for low-risk yet effective early life intervention to prevent the full onset of these problems. To
do so we expand the study of an existing maternal-infant cohort by adding measures, time points, and an older
outcome. We extend the cohort from the toddler years into the preschool period when psychopathology has
begun to take shape and be able to be relatively reliably characterized. Key mechanisms to be examined are (a)
biological signals in early life, focused on maternal inflammation and serotonergic metabolites during pregnancy
and the trajectory of change in those signals in the first three years of life; (b) brain development as indexed by
EEG measures from birth to age 3 years (lower cost and more readily clinically applicable than MRI at this stage);
and (c) behavioral dynamics in early caregiving, about which little is known regarding ADHD risk in the first 24
months of life. The inflammation hypothesis builds on striking preliminary data uncovered by the PI's in their prior
work. The EEG metrics likewise are supported by preliminary evidence. The behavioral data also have strong
preliminary data and build on multiple theorists' proposals about the role of early emotional regulation in
subsequent risk for dysregulatory psychopathology and ADHD. Both baseline (intercept) and change (trajectory)
measures will be examined to help evaluate when in development a particular domain or level of analysis is most
informative to subsequent outcome. Each of these hypotheses is examined in stand-alone fashion, and then
with those findings in hand, an integrative developmental model will be tested. If successful the study will open
new directions for low-risk yet potentially effective early intervention by identifying specific, measurable, and
reversible risk factors or mechanisms as candidates for clinical trial follow up.

## Key facts

- **NIH application ID:** 10537406
- **Project number:** 3R01MH124824-02S1
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** JOEL T NIGG
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $59,533
- **Award type:** 3
- **Project period:** 2022-01-01 → 2024-10-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10537406

## Citation

> US National Institutes of Health, RePORTER application 10537406, Developmental origins and early detection of ADHD and dysregulatory psychopathology (3R01MH124824-02S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10537406. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*